Also known as: VAMP1 Gene Sequencing (Spastic Ataxia Type 1, Autosomal Dominant)
Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3 โ 4 Weeks
VAMP1 Gene Spastic Ataxia Type 1, Autosomal Dominant Genetic Test in UAE
Executive Summary & Core Metrics
DNA Labs UAE offers a highly precise VAMP1 gene sequencing test for diagnosing Autosomal Dominant Spastic Ataxia Type 1. Utilizing advanced NGS technology, the test achieves >99.9% analytical accuracy. The all-inclusive service at 2,800 AED features VIP mobile phlebotomy with temperature-controlled cold-chain logistics, a detailed clinical report, and a post-test genetic counseling session. DNA Labs UAE is fully licensed by the DHA (License No. 1143).
Test Overview & Methodology
This targeted genetic test analyzes the VAMP1 gene for pathogenic mutations responsible for Autosomal Dominant Spastic Ataxia Type 1. The test employs Next-Generation Sequencing (NGS) to detect single nucleotide variants (SNVs), insertions, deletions, and copy number variations (CNVs) with high sensitivity and specificity, providing essential data for accurate clinical diagnosis and informed family planning.
| Feature | Our Test (VAMP1 NGS Panel) | Alternative (Whole Exome Sequencing) |
|---|---|---|
| Analytical Precision | >99.9% for VAMP1 coding regions & splice sites | Lower depth across the exome, may miss mosaic changes |
| Methodology | Targeted NGS with dedicated CNV detection | Whole exome capture + NGS, limited CNV calling |
| Turnaround Time | 3 โ 4 Weeks | 4 โ 6 Weeks |
Physician Insight & Safety Protocols
"Precision genetic testing for VAMP1 mutations allows for definitive diagnosis and empowers families with actionable information for personalized care. At DNA Labs UAE, we adhere to strict clinical validity standards to ensure that every genetic report translates directly into better patient management."
- Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403)
Clinical Safety & Patient Consent Advisory
In accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability, all genetic testing requires explicit informed consent. Our genetic counselors ensure patients understand the scope, benefits, and limitations of the VAMP1 test. Strict confidentiality protocols are maintained throughout the testing lifecycle.
Exclusion Criteria & Emergency Red Flags
- Individuals under 18 years without verified legal guardian consent.
- Active bleeding disorders unless cleared by the referring physician.
- Inability to provide or withdraw informed consent independently.
- Seek immediate emergency care if you experience: sudden worsening of neurological symptoms, respiratory difficulty accompanying ataxia, or suicidal ideation after receiving genetic results.
Patient FAQ & Clinical Guidance
1. What is the VAMP1 gene spastic ataxia test?
This is a targeted DNA test that sequences the VAMP1 gene to detect pathogenic variants causing Autosomal Dominant Spastic Ataxia Type 1. The results confirm the genetic basis of the condition, enabling personalized treatment and risk assessment for family members.
2. How is the sample collected for this test?
A standard peripheral whole blood sample is required. DNA Labs UAE provides a complimentary VIP mobile phlebotomy service, where a trained nurse collects the sample at your home using a temperature-controlled cold-chain system, available daily from 8 AM to 11 PM.
3. What is the turnaround time and what support is provided?
Results are delivered within 3 to 4 weeks. The report includes a detailed clinical interpretation and recommendations from our Consultant Medical Geneticist. A follow-up teleconsultation is arranged to explain the findings and discuss their implications.
UAE Regulatory & Data Privacy Adherence
Trust & Compliance Framework
DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical safety and patient consent protocols are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Our facility is DHA-licensed (No. 1143) and ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | VAMP1 Gene Sequencing (Spastic Ataxia Type 1, Autosomal Dominant) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 โ 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (VIP Mobile Phlebotomy & Cold-Chain Home Collection Available) |
| Methodology Used | Targeted Next-Generation Sequencing (NGS) with CNV Detection |
| ICD-10-CM Code | G11.8 |
| LOINC Code | 82939-0 |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No specific fasting required", "Inform lab of any medications"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians